Evidence map›Paper›PMID 36714210›Full record

ArticleCurrent treatment options in psychiatry2022

Neuromodulation as an Augmenting Strategy for Behavioral Therapies for Anxiety and PTSD: a Narrative Review.

Crystal Lantrip, Yvette Z Szabo, F Andrew Kozel, Paul Holtzheimer

Open access · greenAbstract read
In one paragraph

Article in Current treatment options in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Crystal LantripDepartment of Veterans Affairs, VISN 17 Center of Excellence for Research On Returning War Veterans, Waco, TX 76711, USA.ORCID 0000-0002-4204-4226
Yvette Z SzaboDepartment of Veterans Affairs, VISN 17 Center of Excellence for Research On Returning War Veterans, Waco, TX 76711, USA.
F Andrew KozelDepartment of Behavioral Sciences and Social Medicine, Florida State University, Tallahassee, FL, USA.
Paul HoltzheimerDepartment of Veterans Affairs, National Center for PTSD, White River Junction, VT, USA.
Baylor University · USDartmouth College · USFlorida State University · US

Funding

Repetitive Transcranial Magnetic Stimulation Augmented Written Exposure Therapy for Veterans with PTSDIK2CX002101 · VA · OLIN TEAGUE VETERANS CENTER · PI Crystal Lantrip · 2021 to 2026
–
CSRD VA IK2 CX002101RRD VA IK1 RX003122
6 · The paper itself

Abstract

Purpose of Review: Post-traumatic stress disorder (PTSD) is a prevalent problem. Despite current treatments, symptoms may persist, and neuromodulation therapies show great potential. A growing body of research suggests that transcranial magnetic stimulation (TMS) is effective as a standalone treatment for PTSD, with recent research demonstrating promising use when combined synergistically with behavioral treatments. In this review, we survey this literature including data suggesting mechanisms involved in anxiety and PTSD that may be targeted by neurostimulation. Recent Findings: Evidence suggests the mechanism of action for TMS that contributes to behavioral change may be enhanced neural plasticity via increased functionality of prefrontal and subcortical/limbic structures and associated networks. Some research has demonstrated a behavioral change in PTSD and anxiety due to enhanced extinction learning or improved ability to think flexibly and reduce ruminative tendencies. Growing evidence suggests TMS may be best used as a therapeutic adjunct, at least acutely, for extinction-based exposure therapies in patients by accelerating therapy response. Summary: While TMS has shown promise as a standalone intervention, augmentation with psychotherapy is one avenue of interest. Non-responders to current EBPs might particularly benefit from this sort of targeted approach, and it may shorten treatment length, which would help the successful completion of a course of therapy.

Indexed as

AnxietyExposure therapyPTSDTMSTranscranial magnetic stimulationTrauma

Identifiers

PMID36714210
PMCPMC9881183
OpenAlexW4295563275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.